Laboratory Supplies for Mali, West Africa Clinical Trial
Added: Feb 18, 2016 4:07 pm This notice is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 "Streamlined Procedures for Evaluation and Solicitation for Commercial Items," as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation document will not be issued. Submit offers on RFQ-RML-D-1776361. This solicitation is a request for quotes (RFQ).The solicitation documents and incorporated provisions and clauses are those in effect tough Federal Acquisition Circular (FAC) 2005-86 February 01, 2016.The associated North American Industry Classification System (NAICS) code for this procurement is 339999 with a small business size standard of 500 people.This is not a total small business set aside.The National Institute of Allergy and Infectious Diseases (NIAID), is seeking to purchase laboratory supplies needed for the clinical trial in Mali, West Africa (please see attach schedule of items). All interested companies shall provide quotation(s) for the laboratory supplies meeting the minimum specifications of items listed on the schedule of items.FOB Point shall be Destination; (Sterling, VA) Place of Performance:Mali, West AfricaAfricaAward will be based on the capability of the item offered to meet the above stated salient characteristics and may be quoted Brand name or equal. As well as, price, past performance, delivery date, and the best value to the government. Quoters must include the solicitation number on quotes.The following FAR provisions apply to this acquisition: FAR 52.212-1 Instructions to Offerors Commercial Items (Oct 2015)FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (Nov 2015)Offerors must complete annual representations and certifications on-line at http://www.sam.gov in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items (Please ensure 52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Dec 2014) is updated in your SAM record)FAR 52.222-25 Affirmative Action Compliance (April 1984)FAR 52.204-16 Commercial and Government Entity Code Reporting (July 2015)FAR 52.204-7 System for Award Management (July 2013)FAR 52.203-98 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements - Representation (DEVIATION 2015-02) The following FAR contract clauses apply to this acquisition:FAR 52-212-4 Contract Terms and Conditions Commercial Items (May 2015)FAR 52-212.5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (Feb 2016)FAR 52.203-99 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements (Feb 2015)FAR 52.204-18 Commercial and Government Entity Code Maintenance (July 2015)FAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (Dec 2013)FAR 52.204-9 Personal Identity Verification of Contractor Personnel (Jan 2011)FAR 52.204-13 System for Award Management Maintenance (July 2013)FAR 52.204-19 Incorporation by Reference of Representations and Certifications (Dec 2014)HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (January 2010) 52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Nov 2015)(a) Definitions. "Inverted domestic corporation" and "subsidiary" have the meaning given in the clause of this contract entitled Prohibition on Contracting with Inverted Domestic Corporations (52.209-10).(b) Government agencies are not permitted to use appropriated (or otherwise made available) funds for contracts with either an inverted domestic corporation, or a subsidiary of an inverted domestic corporation, unless the exception at 9.108-2(b) applies or the requirement is waived in accordance with the procedures at 9.108-4.(c) Representation. By submission of its offer, the offeror represents that- (check one)____(1) It is not an inverted domestic corporation: and____(2) It is not a subsidiary of an inverted domestic corporation.By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and tough final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov).Copies of the above-referenced provisions and clauses are available from http://www.acquisition.gov/far/loadmainre.html or, upon request, either by telephone or fax.This is an open-market combined synopsis/solicitation for Laboratory Supplies needed in Mali West Africa. The government intends to award a purchase order as a result of this combined synopsis/solicitation that will include the terms and conditions set forth herein. To facilitate the award process all quotes should include a statement regarding the terms and conditions herein as follows: "The Terms and conditions in the solicitation are acceptable to be included in the award document without modification, deletion or addition."OR"The terms and conditions in the solicitation are acceptable to be included in the award document with the exception, deletion, or addition of the following:"(Quoter shall list exception(s) and rationale for the exception(s).)Submission shall be received not later than February 29, 2016 by 4:30 pm MST.Offers may be mailed, e-mailed to Laura Grey, laura.grey@nih.gov. Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f)All responsible sources may submit an offer that will be considered by this Agency. Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to Laura Grey, laura.grey@nih.gov. RFQ-RML-D-1776361 Department of Health and Human Services National Institutes of Health
2/18/16, 4:07 PM